Showing 381-390 of 2589 results for "".
The Complex World of Biosimilars
https://practicaldermatology.com/topics/psoriasis/the-complex-world-of-biosimilars/18633/Jashin Wu, MD, discusses potential concerns with biosimilars, including the chance of inducing variable immunogenic responses compared with reference agents. Although there are currently no biosimilars approved for use in psoriasis in the United States, these agents are fast approaching market availCosmeceutical Advances in 2016
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmeceutical-advances-in-2016/18622/Suneel Chilukuri, MD discusses recent advances in the cosmeceutical market including a new topical formulated to protect the skin from UVA/UVB damage as well as from infrared radiation, a skin brightening topical formulated to carry retinol deeper into the skin, and a topical hyaluronic acid productUnderstanding Male Aesthetics
https://practicaldermatology.com/topics/practice-management/understanding-male-aesthetics/19118/As the male aesthetic market continues to grow, dermatologists need to understand aesthetic differences between men and women and recognize how these will influence treatment decisions. Terrence Keaney, MD talks about Botox and neurotoxins, dermal fillers, and lasers used to treat men.Cosmeceuticals: It's All About End Results
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/cosmeceuticals-it-s-all-about-end-results/18582/End results separate the science from the marketing of topical cosmetic products, says Annie Chiu, MD. She talks about the challenges of formulating and preserving delicate ingredients and explains why packaging is so important. Patients need education about ingredients and packaging, she says, to oStarting a Practice? Get Educated
https://practicaldermatology.com/topics/practice-management/starting-a-practice-get-educated/19109/You know your medicine, but how well do you know business topics, like human resources, accounting, marketing, staffing, and other aspects of running a practice? Consider hiring a consultant, says Todd Schlesinger, MD, FAAD.An Exciting Year in Dermatology
https://practicaldermatology.com/topics/psoriasis/an-exciting-year-in-dermatology/19929/From new topicals to novel systemic agents, several treatments may be coming to the market in the next two years, while existing therapies may see label expansions. Bruce Strober, MD, PhD offers a look at new MOAs and the evidence for their use.Join Us for NewDerm LIVE: Welcome from the Chairs
https://practicaldermatology.com/topics/practice-management/join-us-for-newderm-live-welcome-from-the-chairs/18920/Join us September 18-20, 2015 at the W Hollywood, CA for NewDerm Live, the meeting that's focused on you—so you can focus on your future. Program chairs Sabrina Fabi, MD, Peter Lio, MD, and Kavita Mariwalla, MD, talk about the goals of the meeting and explain why they decided to be part of this exciScientifically Speaking: Can We Conquer Cellulite?
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-can-we-conquer-cellulite/19872/Treating cellulite has been a challenge, but new and emerging technologies offer hope to overcome this common condition. Host Joel L. Cohen, MD talks with Nazanin Saedi, MD, Endo's Mike McLane, PhD, and Soliton's Wally Klemp.Journal Club: Treating Itch and Lessons from the IL-4 and IL-13 Blockade
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-treating-itch-and-lessons-from-the-il-4-and-il-13-blockade/27025/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, chats with dermatologist Matthew Zirwas, MD, about how evaluations of itch can lead to treatment for atopic dermatitis, and his Journal of Drugs in Dermatology article "Unexpected Clinical Lessons Learned From IL-4 and IL-13 Blockade."New Thinking: Eczema as a Systemic Disease
https://practicaldermatology.com/topics/psoriasis/new-thinking-eczema-as-a-systemic-disease/18756/By Seemal R. Desai, MD and Emma Guttman, MD, PhD, FAADEczema is an immune-driven disease like psoriasis. How is that knowledge changing the way that dermatologists treat patients? Are similar changes taking place for other inflammatory diseases? Dr. Guttman talks about the latest.